XML 23 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Ordinary Share
Additional paid-in capital [Member]
Accumulated deficit [Member]
Total
Balance at Dec. 31, 2018 $ 193 $ 154,670 $ (152,918) $ 1,945
Balance, shares at Dec. 31, 2018 2,813,087      
Share-based compensation to employees and non-employees   1,108   1,108
Issuance of ordinary shares upon vesting of RSUs by employees and non-employees $ 2     2
Issuance of ordinary shares upon vesting of RSUs by employees and non-employees, shares 47,473      
Issuance of ordinary shares in a "best effort" offering, net of issuance expenses in the amount of $686 [1] $ 52 3,632 3,684
Issuance of ordinary shares in a "best effort" offering, net of issuance expenses in the amount of $686, shares [1] 760,000      
Exercise of pre-funded warrants and warrants [1] $ 40 1,461 1,501
Exercise of pre-funded warrants and warrants, shares [1] 584,087      
Issuance of ordinary shares in a "Registered Direct" offering, net of issuance expenses in the amount of $ 1,125 [1] $ 115 8,010 8,125
Issuance of ordinary shares in a "Registered Direct" offering, net of issuance expenses in the amount of $ 1,125, shares [1] 1,650,248      
Issuance of ordinary shares in a "Warrant exercise" agreement, net of issuance expenses in the amount of $ 1,019 [1] $ 102 9,864 9,966
Issuance of ordinary shares in a "Warrant exercise" agreement, net of issuance expenses in the amount of $ 1,019,shares 1,464,665      
Net loss     (15,551) (15,551)
Balance at Dec. 31, 2019 $ 504 178,745 (168,469) 10,780
Balance, shares at Dec. 31, 2019 7,319,560      
Share-based compensation to employees and non-employees   749   749
Issuance of ordinary shares upon vesting of RSUs by employees and non-employees $ 3 (3)  
Issuance of ordinary shares upon vesting of RSUs by employees and non-employees, shares 63,111      
Issuance of ordinary shares in a "Best Efforts" offering, net of issuance expenses in the amount of $ 1,056 [1] $ 290 3,720 4,010
Issuance of ordinary shares in a "Best Efforts" offering, net of issuance expenses in the amount of $ 1,056, shares [1] 4,053,172      
Exercise of pre-funded warrants and warrants [1],[2] $ 244 3,979 4,223
Exercise of pre-funded warrants and warrants, shares [1],[2] 3,378,328      
Issuance of ordinary shares in a "registered direct" offering, net of issuance expenses in the amount of $ 1,019 [1] $ 357 7,624 7,981
Issuance of ordinary shares in a "registered direct" offering, net of issuance expenses in the amount of $ 1,019, shares [1] 4,938,278      
Issuance of ordinary shares in a private placement, net of issuance expenses in the amount of $ 993 [1] $ 429 6,578 7,007
Issuance of ordinary shares in a private placement, net of issuance expenses in the amount of $ 993, shares [1] 5,579,776      
Net loss     (12,976) (12,976)
Balance at Dec. 31, 2020 $ 1,827 201,392 (181,445) 21,774
Balance, shares at Dec. 31, 2020 25,332,225      
Share-based compensation to employees and non-employees   833   833
Issuance of ordinary shares upon vesting of RSUs by employees and non-employees $ 31 (31)  
Issuance of ordinary shares upon vesting of RSUs by employees and non-employees, shares 398,164      
Issuance of ordinary shares in a "Best Efforts" offering, net of issuance expenses in the amount of $ 1,056 [1] $ 832 35,489 36,321
Issuance of ordinary shares in a "Best Efforts" offering, net of issuance expenses in the amount of $ 1,056, shares [1] 10,921,502      
Exercise of pre-funded warrants and warrants [1],[2] $ 772 14,288 15,060
Exercise of pre-funded warrants and warrants, shares [1],[2] 10,425,258      
Issuance of ordinary shares in a "registered direct" offering, net of issuance expenses in the amount of $ 1,019 [1] $ 1,199 26,932 28,131
Issuance of ordinary shares in a "registered direct" offering, net of issuance expenses in the amount of $ 1,019, shares [1] 15,403,014      
Net loss     (12,736) (12,736)
Balance at Dec. 31, 2021 $ 4,661 $ 278,903 $ (194,181) $ 89,383
Balance, shares at Dec. 31, 2021 62,480,163      
[1] See Note 8b.
[2] See Note 8f.